Summary:

Next-gen biofuel and biochemical companies Genomatica and Mascoma have filed notices recently indicating that they plan to go public some time soon. But how are the other next-gen biofuel companies that have gone public in recent months now faring on the stock market? Mostly down.

GevoCodexisstock

Both next-gen biofuel and biochemical companies Genomatica and Mascoma have filed notices in recent weeks indicating that they plan to go public some time soon. But how are the other biofuel companies that have gone public in recent months now faring on the stock market? Well, overall the companies are generally down over the past three months, including Amyris, Gevo, Codexis, and Solazyme. The only outlier seems to be Kior, which was down til September, and then jumped up over the past few weeks, most recently getting a boost from a “buy” rating from Deutsche Bank.

Codexis vs Gevo

Solazyme vs Amyris

Kior

You’re subscribed! If you like, you can update your settings

Comments have been disabled for this post